Current Aspirin News and Events

Current Aspirin News and Events, Aspirin News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Study examines aspirin and statin use among older Americans
An analysis published in the Journal of the American Geriatrics Society indicates that while adults aged 75 years and older do not benefit from taking aspirin to prevent cardiovascular disease, many do so on a regular basis. (2021-02-18)

Aspirin preferred to prevent blood clots in kids after heart surgery
Aspirin should be favoured over warfarin to prevent blood clotting in children who undergo a surgery that replumbs their hearts, according to a new study. (2021-02-14)

Study shows aspirin before a diagnosis may lower colorectal cancer mortality
A new study finds that long-term aspirin use before a diagnosis of colorectal cancer (CRC) may be associated with lower CRC-specific mortality. (2021-02-02)

Does aspirin lower colorectal cancer risk in older adults? It depends on when they start.
A new study has found that there is no protection against colorectal cancer if people begin taking aspirin regularly after age 70. However, there appears to be such protection if aspirin is started before age 70 and continued. (2021-01-21)

Plants on aspirin
For centuries humans were using willow barks to treat a headache or an inflamed tooth. Later, the active ingredient, the plant hormone salicylic acid, was used to develop painkillers like Aspirin. But what happens, if plants are treated with these painkillers? By doing so, Scientists at the Institute of Science and Technology (IST) Austria discovered an unexpected bioactivity of human pharmaceuticals in plants. The scientists published their study in the journal Cell Reports. (2020-12-01)

Newer blood thinner plus aspirin reduced stroke risk by 27% in patients with heart plaque
Patients who suffered a 'warning stroke' were less likely to have another stroke or die within 30 days if treated with a combination of aspirin and a newer blood thinner, ticagrelor. Researchers say that for patients with minor stroke treated within 24 hours of symptom onset, clinicians should consider the combination of ticagrelor plus aspirin to prevent a subsequent stroke. (2020-11-17)

One-month of dual anti-platelet therapy is safe and feasible after stent placement
A short, one-month treatment combining antiplatelet medication and aspirin followed by an aspirin-only regime was as effective as a 6- to 12-month course of dual treatment at preventing death, heart attacks, strokes, bleeding or the need for additional stent placement. The results of this study could lead to changes in treatment and improve patient compliance, lower costs and fewer side effects. (2020-11-16)

New study confirms combo pill alone and with aspirin lowers heart disease risk
A ''polypill'' is a single pill that includes multiple medications to control more than one health risk factor (such as heart disease, high blood pressure, high cholesterol, Type 2 diabetes, kidney disease, stroke). In this large, international trial, the polypill included blood pressure and cholesterol lowering medications for people at risk for heart disease. Results from the randomized, placebo-controlled trial show that the combination of a polypill plus aspirin reduced cardiovascular disease by 31%, and the polypill without aspirin reduced CVD by 21%. (2020-11-13)

Aspirin use best for those with high coronary calcium, low risk of bleeding
DALLAS - Oct. 28, 2020 - An X-ray test commonly used to assess hardening of the arteries could help doctors decide whether the benefits of taking aspirin to prevent a first heart attack or stroke outweigh the risks of bleeding from its use, UT Southwestern research suggests. (2020-10-29)

New study: aspirin use reduces risk of death in hospitalized patients
Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM). (2020-10-22)

Results from the VOYAGER PAD Trial reported at TCT Connect
A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. (2020-10-19)

Three common medications lower risk and mortality for lung cancer
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO). The JTO is the official journal of the International Association for the Study of Lung Cancer. (2020-09-17)

Study reveals best anti-clotting strategy after heart valve intervention
The POPular TAVI trial has challenged current guideline recommendations on antiplatelet treatment after transcatheter aortic valve implantation (TAVI) in patients not taking oral anticoagulation. The findings are presented in a Hot Line session today at ESC Congress 2020. (2020-08-31)

Combo therapy may prevent blood vessel complications in children with Kawasaki disease
For children with Kawasaki disease with higher risk of developing blood vessel complications, adding corticosteroids to standard intravenous immunoglobulin treatment could boost initial treatment response and prevent complications. Researchers used real-world data from large, nationwide Japanese Kawasaki disease surveys to compare combination therapy with the standard treatment. (2020-08-19)

NIH study suggests opioid use linked to pregnancy loss, lower chance of conception
Opioid use among women trying to conceive may be associated with a lower chance of pregnancy, suggests a National Institutes of Health study. Moreover, opioid use in early pregnancy may be associated with a greater chance of pregnancy loss. (2020-08-18)

Aspirin may accelerate progression of advanced cancers in older adults
For older adults with advanced cancer, initiating aspirin may increase their risk of disease progression and early death. (2020-08-10)

Study finds increase in number, severity of suicide-related calls to US Poison Control
Researchers at the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children's Hospital analyzed the 549,807 calls made to Poison Control Centers (PCCs) in the U.S. for suicide-related cases involving OTC analgesics from 2000 through 2018 and found that both the overall number and rate of these cases increased significantly by 57% and 34%, respectively, during this period. (2020-07-27)

NSAIDs increase cardiovascular, bleeding risk in Korean heart attack patients
Use of NSAIDs to treat first-time heart attack patients significantly increased the risk for cardiovascular and bleeding events post-heart attack in a nationwide Korean study, published today in the Journal of the American College of Cardiology. (2020-07-27)

COVID-19 causes 'hyperactivity' in blood-clotting cells
Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists. The researchers found that inflammatory proteins produced during infection significantly alter the function of platelets, making them ''hyperactive'' and more prone to form dangerous and potentially deadly blood clots. (2020-06-30)

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed. (2020-06-11)

Aspirin reduces long-term colorectal cancer risk in genetically predisposed individuals
Aspirin reduces colorectal cancer risk by half in individuals at high genetic risk. Preventive efficacy is prolonged for 10-20 years after treatment with aspirin. (2020-06-11)

What are the risks and benefits of low-dose aspirin?
Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology. (2020-06-03)

Two paths better than one for treating patients with heart stents
Pairing a blood-thinning drug with aspirin daily for patients who have an angioplasty with a stent can contribute to better health outcomes, including lower risk of death, than aspirin alone, according to a recent study by cardiologists at the University of Alberta and Mazankowski Alberta Heart Institute. (2020-05-28)

Half of moms-to-be at risk of preeclampsia are missing out on preventive aspirin
More than half of moms-to-be who are at risk of the dangerously high blood pressure condition, preeclampsia, are missing out on preventive aspirin treatment, says an expert in an editorial published online in Drug and Therapeutics Bulletin. (2020-05-21)

Some recommended cardiovascular medications prescribed less frequently to women
In primary care, sex differences for recommended cardiovascular (CVD) prescriptions were found for patients who were at high risk or who had CVD. Women were less likely than men to receive cholesterol-lowering medicines and aspirin, yet equally likely to receive blood-pressure-lowering medications. (2020-05-20)

Heart attack prevention lags for people with stroke, peripheral artery disease
Although all three conditions can lead to heart attack, people with stroke or peripheral artery disease were less likely to receive preventive treatments to prevent heart attack than people with coronary artery disease. Stroke survivors were more likely to report poor health care satisfaction and more emergency room visits. Patients with peripheral artery disease had the highest out-of-pocket health expenses of the three conditions. (2020-05-16)

Safety of bioabsorbable polymer against durable polymer DES in high-risk PCI patients
A novel study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) presented a safety advantage without compromising efficacy compared to durable polymer (DP) formulations. Subgroup findings from the TWILIGHT trial were presented today during the SCAI 2020 Scientific Sessions Virtual Conference. (2020-05-14)

Temple finds link between blood vessel inflammation, malfunctioning cellular powerhouses
In new research, scientists at the Lewis Katz School of Medicine at Temple University have uncovered a novel mechanism by which abnormalities in mitochondrial fission in endothelial cells contribute to inflammation and oxidative stress in the cardiovascular system. They further show how the fission-fusion balance can be stabilized to lower inflammation using salicylate, the main active ingredient in everyday pain-relieving drugs like aspirin. The groundbreaking research was published online May 11, 2020 in the journal Hypertension. (2020-05-11)

Prime time for lower extremity artery disease
This article provides an overview of the indications and techniques of lower extremity revascularisation, and an in-depth analysis of the available evidence regarding type and duration of antiplatelet and anticoagulant treatment following endovascular and surgical revascularisation. (2020-05-06)

Aspirin linked to reduction in risk of several cancers of the digestive tract
The largest and most comprehensive analysis to date of the link between aspirin and cancers of the digestive tract has shown that it is associated not only with a significant reduction in the risk of developing bowel cancer but also of several other cancers that almost invariably fatal, such as pancreatic and liver cancers. The study is published in Annals of Oncology. (2020-04-15)

Rivaroxaban reduces risk in symptomatic PAD post-intervention
People with symptomatic peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Clopidogrel atop rivaroxaban and aspirin shows no added benefit for PAD
The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who took the blood thinner rivaroxaban with aspirin after undergoing lower extremity revascularization -- a procedure to treat blocked arteries in the leg -- had a significant reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to a subgroup analysis from VOYAGER PAD presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Ticagrelor alone, without aspirin, shows benefit in patients with diabetes
Patients with diabetes who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year. The research was presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Dropping aspirin for ticagrelor alone better in complex heart disease
The research, a subanalysis of the TWILIGHT trial, was presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Benefit seen for ticagrelor alone, without aspirin, in patients with ACS
The research was presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Study: An aspirin a day does not keep dementia at bay
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer's disease, nor does it slow the rate of cognitive decline, according to a large study published in the March 25, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. (2020-03-25)

Low-dose aspirin linked to reduced liver cancer risk
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes. (2020-03-12)

Secondary analysis confirms safety of blood thinning agent
The blood thinner apixaban, which treats and prevents blood clots in some people with irregular heart rhythm, is safe and effective in stroke patients. Apixaban is associated with less bleeding, death and hospitalization than warfarin. (2020-02-21)

Researchers challenge new guidelines on aspirin in primary prevention
New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at higher risks of cardiovascular events than those under 70. As a result, health care providers are understandably confused about whether or not to prescribe aspirin for primary prevention of heart attacks or strokes, and if so, to whom. (2020-02-17)

Common medication may lower risk of 'broken heart' during bereavement
The increased risk of heart attack or 'a broken heart' in early bereavement could be reduced by using common medication in a novel way, according to a world-first study led by the University of Sydney and funded by Heart Research Australia. (2020-02-10)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.